These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 33119942

  • 1. Biosafety Level 2 cabinet UV-C light exposure of sports antidoping human urine samples does not affect the stability of selected prohibited substances.
    Voss S, Abushreeda W, Vonaparti A, Al-Wahaibi A, Al-Sowaidi N, Al-Mohannadi I, Mahieddine S, Khelifi S, Salama S, Saleh A, Al-Mohannadi M, El-Saftawy W, Al-Hamad K, Nofal A, Dbes N, Aguilera R, Al Maadheed M, Georgakopoulos C.
    Drug Test Anal; 2021 Feb; 13(2):460-465. PubMed ID: 33119942
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 7-keto-DHEAmetabolism in humans. Pitfalls in interpreting the analytical results in the antidoping field.
    Martinez-Brito D, de la Torre X, Colamonici C, Curcio D, Botrè F.
    Drug Test Anal; 2019 Nov; 11(11-12):1629-1643. PubMed ID: 31701664
    [Abstract] [Full Text] [Related]

  • 4. High-throughput liquid chromatography tandem mass spectrometry assay as initial testing procedure for analysis of total urinary fraction.
    Sobolevsky T, Ahrens B.
    Drug Test Anal; 2021 Feb; 13(2):283-298. PubMed ID: 32852861
    [Abstract] [Full Text] [Related]

  • 5. The potential role of oral fluid in antidoping testing.
    Anizan S, Huestis MA.
    Clin Chem; 2014 Feb; 60(2):307-22. PubMed ID: 24153253
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gas chromatographic quadrupole time-of-flight full scan high resolution mass spectrometric screening of human urine in antidoping analysis.
    Abushareeda W, Lyris E, Kraiem S, Wahaibi AA, Alyazidi S, Dbes N, Lommen A, Nielen M, Horvatovich PL, Alsayrafi M, Georgakopoulos C.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep 15; 1063():74-83. PubMed ID: 28850889
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Doping in sports].
    Jeschke J, Nekola J, Chlumský J.
    Cas Lek Cesk; 1999 May 10; 138(10):291-7. PubMed ID: 10422337
    [Abstract] [Full Text] [Related]

  • 12. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry.
    Kolmonen M, Leinonen A, Pelander A, Ojanperä I.
    Anal Chim Acta; 2007 Feb 28; 585(1):94-102. PubMed ID: 17386652
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sports drug testing using complementary matrices: Advantages and limitations.
    Thevis M, Geyer H, Tretzel L, Schänzer W.
    J Pharm Biomed Anal; 2016 Oct 25; 130():220-230. PubMed ID: 27040951
    [Abstract] [Full Text] [Related]

  • 15. Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples.
    Hullstein IR, Malerod-Fjeld H, Dehnes Y, Hemmersbach P.
    Drug Test Anal; 2015 Oct 25; 7(11-12):1025-9. PubMed ID: 26607218
    [Abstract] [Full Text] [Related]

  • 16. Compared interest between hair analysis and urinalysis in doping controls. Results for amphetamines, corticosteroids and anabolic steroids in racing cyclists.
    Gaillard Y, Vayssette F, Pépin G.
    Forensic Sci Int; 2000 Jan 10; 107(1-3):361-79. PubMed ID: 10689587
    [Abstract] [Full Text] [Related]

  • 17. Pilot study on the effects of intravesical oxybutynin hydrochloride instillations on the validity of doping control urine samples.
    Walpurgis K, Scheiff AB, Welz M, Müller-Reul J, Webborn N, Görgens C, Guddat S, Fußhöller G, Dib J, Thevis M.
    Drug Test Anal; 2019 Nov 10; 11(11-12):1755-1760. PubMed ID: 31670462
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.